Summary The European Childhood Leukaemia-Lymphoma Incidence Study (ECLIS) is designed to address concerns about a possible increase in the risk of cancer in Europe following the nuclear accident in Chernobyl in 1986. This paper reports results of surveillance of childhood leukaemia in cancer registry populations from 1980 up to the end of 1991. There was a slight increase in the incidence of childhood leukaemia in Europe during this period, but the overall geographical pattern of change bears no relation to estimated exposure to radiation resulting from the accident. We conclude that at this stage of follow-up any changes in incidence consequent upon the Chernobyl accident remain undetectable against the usual background rates. Our results are consistent with current estimates of the leukaemogenic risk of radiation exposure, which, outside the immediate vicinity of the accident, was small.
The accident at the Chernobyl nuclear power plant in the Ukraine on 26 April 1986 resulted in the dissemination of radioactive isotopes (principally "lI and 137Cs) across a wide area of Europe. The concern that this generated, particularly regarding the risk of cancers induced by excess radiation exposure, led to the establishment of the European Childhood Leukaemia-Lymphoma Incidence Study (ECLIS) to monitor trends in these diseases in relation to the estimated exposure levels. The rationale for choosing childhood leukaemia for this monitoring exercise has been described elsewhere (Parkin, 1990; Doll et al., 1990 ). Briefly, leukaemia shows the earliest and largest relative increase in risk following radiation exposure, and the risk from exposure in childhood is greater than at older ages (Shimizu et al., 1990; Preston et al., 1994) . In addition, the availability and quality of data for childhood cancers tend to be greater than for cancers in adults.
A previous paper describes the background and methods of the study (Parkin et al., 1993) ; here we present the results of follow-up to the end of 1991, more than 5 years after exposure began.
Materials and methods

Cancer data
Thirty-six cancer registries in 23 countries are collaborating in ECLIS by supplying an annual listing of cases of leukaemia and lymphoma occurring in children aged less than 15 years. For each case included in the present analysis, the data comprised six variables: date of diagnosis, date of birth, sex, place of residence, basis of diagnosis and diagnosis code [ICD-0 (1st edn) for most registries]. In this paper, we confine analysis to cases of leukaemia, for which a total of 23 756 cases were reported by the collaborating centres in the period 1980 -91.
Population at risk Person -years at risk by sex and single year of age were calculated for the regions covered by the participating registries, based on annual mid-year estimates of the populations obtained by participants from national bureaux of censuses and statistics. A total of 655 million personyears of observation have now been accumulated from 1980 to 1991 (61% before and 39% after the accident).
Radiation exposure assessment The source of data on radiation exposure due to the accident was the United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR), as described previously (Parkin et al., 1993) . The data were supplied as the estimated doses during the first year, years 0-4, and years 0-70 following the accident in different regions of Europe (the term 'dose' is used to mean individual committed effective equivalent dose resulting from exposure in a given time period). The geographical units for which these estimates were produced were either whole countries or, where the distribution of exposures within a given country was uneven, for two to four subregions within the country. Figure 1 shows the countries and subregions for which the dose estimates were available. Table I lists the 35 regions for which data have been  contributed for the study (see below) , and the corresponding dose estimates supplied by UNSCEAR. For some of the regions listed in Table I only part of the population is  covered by cancer registries, for example France (region 3) , Italy (region 1), Switzerland (regions 2, 3 and 4), Romania and the former Soviet Union (regions 3 and 4).
The UNSCEAR estimates of exposure were used to obtain estimates of the average leukaemogenic dose received by children in the study regions according to the following assumptions: Figure 1 Europe, showing the countries and geographical regions for which environmental exposure estimates are available from UNSCEAR (1988) (within a country the numbers refer to the regions and do not imply any ranking). The shaded areas represent those from which cancer data were available in the current analysis.
(1) The leukaemogenic effect of environmental radiation exposure has a latency of 1 year (this means that, for example, it is assumed that only the dose received in utero has an effect in the first year after birth); (2) The effective dose to the fetus is the same as that to a free-living individual (as most of the radiation from the accident is received internally, from '34Cs and '37Cs ingested with contaminated food); (3) The total leukaemogenic dose is cumulative, starting with exposure at conception.
The estimated cumulative doses at the end of the first, fourth and seventieth years after the accident are shown in Table I . Figure 2 illustrates the method used to establish dose estimates for the person -years at risk. The estimated cumulative dose of an individual aged a at date t was calculated by integrating the dose over time from conception until t-l, where 1 is the assumed latency. For this purpose, the dose was assumed to fall linearly throughout the first year following the accident and exponentially thereafter. Finally, these cumulative doses were averaged over calendar years and single years of age in order to establish compatibility within the leukaemia incidence data. (-1980, 1981-86, 1987 and 1988-) were obtained by fitting Age Group*Dose and Cohort*Dose interaction terms. The same categories of age and birth cohort were used in the presentation of results.
Results
The radiation exposure to the populations of all the regions studied due to Chernobyl was small, with the highest level at about 2 mSv in year 1 in Belarus (Table I ). This is slightly lower than the natural background annual dose (around 2.4 mSv).
The model fitting results are summarised in Table II base model, in which differences in the age distributions between regions were unrestricted, there was no indication of an age-specific effect of dose. In all study regions combined, there was an increase in the overall age-standardised rate of childhood leukaemia in the period 1980-86 (average annual change +0.6%). There is no indication of an increase in the gradient of this trend after the Chernobyl accident in 1987-91 (average annual change +0.4%). Neither is there any evidence of change in trends in age-specific rates before and after the accident, as shown in Figure 4 . provide an opportunity for testing the dose effect but there was no suggestion, either of heterogeneity between the dose categories (X' = 0.98, 3 d.f. or of a trend with dose when fitted as a continuous variable (X'=0.85, 1 d.f.).
We considered whether or not use of the most complex model 3 involved a loss of statistical power to detect an exposure effect. Table II shows that, as expected, the standard error of the dose effect increases with the complexity of the base models, but to a negligible extent. The standard error of the dose parameter estimate of model 3 was used to assess the power of the study to detect effects of the magnitude observed in other exposed populations. These power estimates, based on one-sided tests at the 5% level of statistical significance, are reported in the Discussion. 
Discussion
Based upon the estimates of excess relative risk of leukaemia in children exposed to radiation from the atomic bombs in Hiroshima and Nagasaki, we estimated that the number of cases of childhood leukaemia expected as a result of the firstyear exposures to radiation from Chernobyl would be too small to distinguish from the background incidence rate (Parkin, 1990) . The only possible exception was in Belarus, where the average first-year excess effective dose equivalent (2 mSv) was about the same as the normal background radiation level, which could increase incidence by about 6%, if the BEIR V estimates apply (Parkin, 1990) . After 5 years of follow-up the power of the study to detect an excess of this magnitude (approximately 25 cases) is still less than 80%.
We observed a small increase in leukaemia incidence over time in Europe as a whole, but there did not appear to be any association between the overall risk of leukaemia in the period 1987-91 and the estimated doses received (after allowance for the effects of age, sex, time and region of residence). Again, however, it should be noted that, at this stage of follow-up, the study has low power to detect a trend in risk with dose. If the excess risk per unit dose estimated from the atomic bomb survivors (Doll et al., 1990 ) is applied to the childhood population at risk following the Chernobyl accident, then the power of the study is about 50%. This may overstate the statistical power, since the protracted low-dose exposures due to the accident differ in quality, and probably also in leukaemogenic effect, from the acute high-dose exposures associated with the atomic bombings.
Although the effect of in utero exposure to radiation remains controversial, some studies, particularly the Oxford Survey of Childhood Cancers, have found a markedly higher risk associated with irradiation during the first trimester of pregnancy (UNSCEAR, 1994) . However, we found no suggestion of an increase in risk of childhood leukaemia for children exposed in utero, even among the 1987 birth cohort in Belarus, some of whom would have received in utero exposures in excess of 1 mSv.
We estimated the leukaemogenic dose of radiation by assuming a 1 year latency between exposure and effect, and that the effect of radiation exposure would be cumulative. This assumption is based on the observation that leukaemia risk increases quite rapidly after exposure to external radiation (Darby et al., 1987) ; increasing the latency period to 2 years before estimating dose has the effect of producing smaller cumulative dose estimates but had no effect on results. It is recognised that adjustments could have been made to the estimates of the effective dose to average individuals (adults) in order to provide more appropriate dose values for consideration of leukaemia incidence in children, for example (1 d.f.) Obs, observed; exp, expected.
-lukoda ab CFw DM Parkin et i X 1011 by using food consumption amounts for children and by considering more specifically the equivalent dose to the bone marrow. For the latter parameter, the internal dose from '"'I contributes somewhat to the effective dose but much less to the equivalent dose to the bone marrow. For most such considerations, the dose estimates would be reduced only slightly. It has also been noted that dose estimates based on environmental transfer of radionucides, as assumed here, have overesimated the effective dose when comparisons could be made with whole-body measurements. The dose estimates are thus only broadly indicative of actual doses that may have been received in specific areas and are probably somewhat overestimated.
The study has been analysed as a cohort study, with the allocation of dose to individuals as a function of place of residence and time since the accident. The actual exposure of individuals within the populations studied is unknown, of course, and imputed values from the population averages were used. Migration between study regions would give rise to exposure misclassification and attenuation of the estimated effect. However, it is ikely that inter-regional migration of children in the 5 years of post-accident observation time has been small and will contribute only to a small extent to incorrect exposure estimation.
We chose to use the UNSCEAR estimates of average effective dose equivalents for quite large areas, since these were available for the whole of Europe. Certain national bodies have produced their own estimates, based on different sets of assumptions and models but generally offering more geographical precision, and these have been used in two recent studies. Thus, ground levels of radiation from '37Cs in Sweden measured in May-October 1986 were used to divide the childhood population into 'unexposed' (<10 kBq m-) and 'exposed' (>lO kBq m-) groups in order to compare leukaemia incidence before and after the Chernobyl accident (Hjalmars et al., 1994) . The population weighted mean of environmental '37Cs contamination in the exposed region (29 Bq m-2) (which corresponds almost exactly to region 1 of Sweden in Figure 1 ) is the same as the UNSCEAR (1988) estimate (31 Bq m-2) used as the basis of dose calculation in the present report. Six and a half years after the accident, 50 cases of leukaemia would be expected in the 'exposed' population in which individuals would have received a cumulative dose of around 1 mSv (Table I) , giving an expected excess relative risk (ERR) of 3-5%, or 1-3 additional cases. It is clear that this Swedish study had no prospect of detecting a statistically significant excess incidence of childhood leukaemia unless the generally accepted assumptions about radiation leukaemogenesis are incorrect by a factor of 5-10. In a study using more appropriate epidemiological methods conducted in Finland (Auvinen et al., 1994) , the average population dose (0.41 mSv over 2 years), derived from atmospheric sampling and whole-body counts, was partitioned in quintiles. The 95% confidence interval of the ERR estimate was -0.27 to +0.41. This range includes a leukaemogenic effect that is almost ten times greater than is conventionally assumed (0.045). The authors of these two studies imply that more accurate dose estimation confers an advantage over ECLIS. It seems obvious that any such advantage is heavily outweighed by lack of power to detect an effect. Ivanov et al. (1993) have compared incidence rates of childhood leukaemia in Belarus before and after (1986-91) the Chernobyl accident for regions with 'severe', 'intermediate' and 'least' radioactive contamination. No differences in incidence were reported. These results are difficult to evaluate, since no quantitative information on exposure is given.
A possible source of bias in this study is differential ascertainment of cases correlated with exposure; for example, as a result of improved detection of cases in heavily exposed populations living near Chernobyl. It is a potential problem for cancers that can exist in a 'latent' form and be diagnosed as a consequence of an active search for them. Ascertainment bias was suggested as a possible cause of the reported excess of thyroid cancer in children in Belarus (Beral and Reeves, 1992; Ron et al., 1992) , although this now seems an unlikely explanation (Williams et al., 1993) . There is no evidence of ascertainment bias in data for childhood leukaemia in Europe. Data submitted to ECLIS are checked for the traditional indicators of data quality used by cancer registries, including the proportion of leukaemia cases of unspecified cell type and the proportion with a histological diagnosis (Parkin et al., 1993) . Although most registries do show small improvements in the latter indicator, there was, in fact, no association between the observed change (1987-91 vs 1980-85) and the estimated radiation dose.
The study will continue data collection for a period of 10 years post accident, so that the full potential of the excess radiation exposure can be studied. Future studies will examine in more detail the trends in incidence within different age groups and geographical regions, estimate the possible effects of migration and study separately urban and rural populations.
